Abstract:Regenerating gene (Reg or REG) family, within the superfamily of C-type lectin, is mainly involved in the liver, pancreatic, gastric and intestinal cell proliferation or differentiation. Considerable attention has focused on Reg family and its structurally related molecules. Over the last 15 years, 17 members of the Reg family have been cloned and sequenced. They have been considered as members of a conserved protein family sharing structural and some functional properties being involved in injury, inflammation, diabetes and carcinogenesis. We previously identified Reg IV as a strong candidate for a gene that was highly expressed in colorectal adenoma when compared to normal mucosa based on suppression subtractive hybridization (SSH), reverse Northern blot, semi-quantitative reverse transcriptase PCR (RT-PCR) and Northern blot. In situ hybridization results further support that overexpression of Reg IV may be an early event in colorectal carcinogenesis. We suggest that detection of Reg IV overexpression might be useful in the early diagnosis of carcinomatous transformation of adenoma. This review summarizes the roles of Reg family in diseases in the literature as well as our recent results of Reg IV in colorectal cancer. The biological properties of Reg family and its possible roles in human diseases are discussed. We particularly focus on the roles of Reg family as sensitive reactants of tissue injury, prognostic indicators of tumor survival and early biomarkers of carcinogenesis. In addition to our current understanding of Reg gene functions, we postulate that there might be relationships between Reg family and microsatellite instability, apoptosis and cancer with a poor prognosis. Investigation of the correlation between tumor Reg expression and survival rate, and analysis of the Reg gene status in human malignancies, are required to elucidate the biologic consequences of Reg gene expression, the implications for Reg gene regulation of cell growth, tumorigenesis, and the progression of cancer. It needs to be further attested whether Reg gene family is applicable in early detection of cancer and whether Reg and Reg-related molecules can offer novel molecular targets for anticancer therapeutics. This has implications with regard to prognosis, such as in monitoring cancer initiation, progression and recurrence, as well as the design of chemotherapeutic drugs.

Advances in RegIV and Alimentary System Neoplasms

RegIV Expression Showing Specificity to Gastrointestinal Tract and Its Potential Role in Diagnosing Digestive Tract Neuroendocrine Tumor

Reg4 expression and signification in gastrointestinal carcinoma

Reg Gene Family and Human Diseases.

The study of regeneration gene I in an atrophic gastritis rat model

Prognostic Value of Amphiregulin and Epiregulin Mrna Expression in Metastatic Colorectal Cancer Patients

Reg proteins and their roles in inflammation and cancer of the human digestive system.

Expression of Reg IV and Hath1 in neuroendocrine neoplasms

Role of REG Iα in Gastric Carcinogenesis: Gastrin-associated Proliferative and Anti-Apoptotic Activities.

Expression of reg I alpha protein in human gastric cancers

REG4 promotes the proliferation and anti-apoptosis of cancer

[The Relation Between Reg 1A Mrna Expression and the Clinicopathologic Parameters in the Patients with Primary Gastric Carcinoma].

Overexpression of Reg IV in colorectal adenoma.

Reg IV, a Differentially Expressed Gene in Colorectal Adenoma.

Advance in the Research of Regenerating Gene Protein

Expression of REG4 in Ovarian Mucinous Tumors.

Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers

The Clinical Significance and Mechanisms of REG4 in Human Cancers

[Construction of RegIα Over-Expression Vector and Its Effect on Proliferation and Apoptosis of Gastric Cancer Cells].

Possible Roles of Reg Family Proteins in Pancreatic Islet Cell Growth.

Decreased REG1α Expression Suppresses Growth, Invasion and Angiogenesis of Bladder Cancer.